Citizen Portal
Sign In

Get AI Briefings, Transcripts & Alerts on Local & National Government Meetings — Forever.

Committee narrows kratom ban to high‑concentration synthetics, approves bill as amended

Finance - Division I · May 5, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Lawmakers passed an amendment that targets semi‑synthetic and synthetic kratom products with 7‑hydroxymitragynine concentrations above 1,000 parts per million and then recommended the amended Senate Bill 557 by vote; LBA described fiscal impact as indeterminable if criminal prosecutions occur.

The committee took up Senate Bill 557, which would make it illegal for liquor‑commission licensees to sell, distribute or otherwise furnish certain kratom products. Representative Sweeney moved the 'ought to pass' motion and offered an amendment narrowing the illegal‑product definition to semi‑synthetic and synthetic kratom containing 7‑hydroxymitragynine above 1,000 parts per million (dry weight).

Sweeney described the intention as excluding traditional, low‑concentration kratom leaf products while removing concentrated synthetics she and stakeholders described as dangerous. "The amendment ... makes us that we're banning semi and semi synthetics and full synthetics, defining them as a product containing 7 hydroxomycrogylinine ... concentrated at a level above 1,000 parts per million on a dry weight basis," she said during explanation of the proposal.

The Legislative Budget Assistant characterized the fiscal note for the Senate version as indeterminable to the extent prosecutions occur. For the House version, the commission said it could absorb enforcement within current duties. Committee members pressed on enforcement practicality and measurement, noting labels are unlikely to carry laboratory concentrations and that forensic testing or post‑incident analysis may be required.

The amendment passed on a roll call, 6–3. The committee then voted 8–1 to recommend passage of SB 557 as amended.

Authorities and enforcement mechanisms discussed included references to RSA 175 (liquor commission statutes) and the Controlled Drug Act (3:18‑b) as the framework for enforcement if the amendment were adopted.

The committee record shows a narrow approach to banning high‑concentration synthetic kratom products while preserving the sale of low‑concentration and natural kratom items under current commerce.